A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
about
Cancer Metabolomics and the Human Metabolome DatabaseTranslational metabolomics in cancer researchHead mass in chronic pancreatitis: Inflammatory or malignantPancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parametersRandom Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis.Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous NeoplasmSerum metabolomics differentiating pancreatic cancer from new-onset diabetes.1HNMR-based metabolomic profile of rats with experimental acute pancreatitis.MALDI-mass spectrometric imaging for the investigation of metabolites in Medicago truncatula root nodulesElevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.Metabolomics for biomarker discovery in gastroenterological cancer.Optimization and comparison of multiple MALDI matrix application methods for small molecule mass spectrometric imaging.Plasma metabolite biomarkers for the detection of pancreatic cancerA Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid ProfileProfiling of plasma metabolites in canine oral melanoma using gas chromatography-mass spectrometry.1H NMR Metabolomics Reveals Association of High Expression of Inositol 1, 4, 5 Trisphosphate Receptor and Metabolites in Breast Cancer PatientsBiomarker Discovery and Translation in Metabolomics.Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer.Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal CancerA review of applications of metabolomics in cancer.Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of ¹H-NMR Spectroscopy and Gas Chromatography-Mass Spectrometry.Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics.Plasma-free amino acid profiles are predictors of cancer and diabetes development.Review article: breath analysis in inflammatory bowel diseases.Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer.Metabolomics in pancreatic cancer biomarkers research.Early detection of pancreatic cancer: Where are we now and where are we going?A Systematic Strategy for Screening and Application of Specific Biomarkers in Hepatotoxicity Using Metabolomics Combined With ROC Curves and SVMs.Simultaneous Quantification of Serum Multi-Phospholipids as Potential Biomarkers for Differentiating Different Pathophysiological states of lung, stomach, intestine, and pancreasMetabolomic biomarkers of pancreatic cancer: a meta-analysis study.Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia.A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis.Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling.Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis.Novel serum metabolomics-based approach by gas chromatography/triple quadrupole mass spectrometry for detection of human skin cancers: Candidate biomarkers.Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.High-throughput and high-sensitivity quantitative analysis of serum unsaturated fatty acids by chip-based nanoelectrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry: early stage diagnostic biomarkers of pancreatic cancerCirculating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.Metabolome analysis for pancreatic cancer risk in nested case-control study: Japan Public Health Center-based prospective Study.Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer.
P2860
Q26767342-78CB91D0-C930-4F3F-8EFC-D013BEE0FB13Q26998663-261269A3-02D5-4454-8EAD-0BB71F589697Q27011806-43F6A714-710C-4F04-8B4D-0C62EB6F8C6FQ27022231-B0E91B92-D8DA-4CDA-AE80-7B3DBF494B39Q31126519-92E6059E-DABB-4FCF-8B93-7CC91DAA3D89Q33635144-3F078E8D-552F-4A24-A645-066B08474BD2Q33710031-37F26DB2-307A-48E7-8D23-CEB9871ABB35Q33909240-EDF5B2DF-C61F-4B1B-BAEB-2B7D747867F7Q34082136-92E2A164-86F7-48E2-BB2C-EB6ED0EDD6B6Q34315320-52CE0811-27B8-407C-A6BB-163D75EF8782Q34318206-43FE8698-C4EC-480C-AA92-3079047F34AAQ34379803-B978ADD3-E68D-483F-A021-9E1724C9FCB0Q35072866-98610DD7-C823-470C-A0DF-EE3F4F71DE0DQ35680475-71928226-8DF7-475F-8EEB-A1CC6A0E06CDQ36048320-79C86D1E-88C9-498A-A6DC-4D5573C0C19EQ36245590-B4C866A0-A9E7-47D2-A6F8-9F3198CBCBBFQ36845593-2586AB10-2ED3-4DDB-B033-47BE67231CD7Q37022332-6266C27F-80A2-485B-9AF0-65368AC2E5A7Q37399898-6CFDFE1E-14B1-4724-AD5B-D534B36E1C93Q37512830-2E35ACEF-E8D0-4DCF-893D-19DAD816670CQ37728545-EB346691-BE37-442D-A7B1-5DC42BF08891Q37733470-98AD944E-FF10-4BDE-9F1D-75E36E90CC27Q37737774-5520B9AC-5DF8-4CFB-B34F-E745B3ED4422Q38293574-411764D0-C15D-47D3-AE34-F9918AF46CAEQ38965713-E30854E0-D89B-42F6-ABCA-2C5C5DC5AE18Q38997162-A4F07495-C469-4C72-80AF-E3BE1FBED4ACQ39152619-00B6EDA2-0B4C-4D77-89D1-F479D37F06D1Q40092878-40977A97-DC18-4C79-AABB-1C385E8A1819Q41440976-1CF74712-DA75-46B0-8BE2-D49433BA3210Q42154484-0800F6B6-4C6D-49D0-9C0E-3A9F2F9FD3A9Q43104456-3B101574-C7CA-48AC-BF9F-352C55B4A491Q43508439-87D95BF2-EF9B-4089-9BF4-CB997380A4BBQ46860779-0164D8F4-8F65-4182-BF1C-EA9A94A33E93Q47179835-11238C66-070E-488A-8F9D-EE2F1CC73602Q48308467-FAE62141-B5B7-4377-B945-1E0CC0D53AC1Q49701167-D544FD80-EFC8-445D-8058-28E04DE593ADQ51521398-32273AAE-29F6-4A9E-B378-344DB7D6068DQ52595056-C1692A60-C325-4BAA-81F6-24139A1B6007Q52633517-2FA5B71F-51E1-4BA6-BEA4-EF9B6D3536E1Q52998486-F3829678-AAA1-4155-B0B6-64060F026774
P2860
A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
@ast
A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
@en
A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
@nl
type
label
A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
@ast
A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
@en
A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
@nl
prefLabel
A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
@ast
A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
@en
A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
@nl
P2093
P1476
A novel serum metabolomics-based diagnostic approach to pancreatic cancer
@en
P2093
Atsuki Ikeda
Atsuki Matsubara
Hidetaka Tsumura
Hironobu Minami
Hogara Nishisaki
Masahiro Tsuda
Masaru Yoshida
Nobuhide Hayashi
Seiji Kawano
P304
P356
10.1158/1055-9965.EPI-12-1033
P577
2013-03-29T00:00:00Z